Correlation Between BioLine RX and Compugen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioLine RX and Compugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLine RX and Compugen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLine RX and Compugen, you can compare the effects of market volatilities on BioLine RX and Compugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLine RX with a short position of Compugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLine RX and Compugen.

Diversification Opportunities for BioLine RX and Compugen

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioLine and Compugen is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding BioLine RX and Compugen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compugen and BioLine RX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLine RX are associated (or correlated) with Compugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compugen has no effect on the direction of BioLine RX i.e., BioLine RX and Compugen go up and down completely randomly.

Pair Corralation between BioLine RX and Compugen

Assuming the 90 days trading horizon BioLine RX is expected to under-perform the Compugen. In addition to that, BioLine RX is 1.78 times more volatile than Compugen. It trades about -0.27 of its total potential returns per unit of risk. Compugen is currently generating about 0.13 per unit of volatility. If you would invest  55,360  in Compugen on December 2, 2024 and sell it today you would earn a total of  15,760  from holding Compugen or generate 28.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BioLine RX  vs.  Compugen

 Performance 
       Timeline  
BioLine RX 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BioLine RX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Compugen 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Compugen are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Compugen sustained solid returns over the last few months and may actually be approaching a breakup point.

BioLine RX and Compugen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioLine RX and Compugen

The main advantage of trading using opposite BioLine RX and Compugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLine RX position performs unexpectedly, Compugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will offset losses from the drop in Compugen's long position.
The idea behind BioLine RX and Compugen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity